Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F0N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,873
Award facts
- Contract value 100% obligated
- $15,872.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $15,872.60 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens. This contract, executed on December 1, 2025, with an ultimate completion date of December 2, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its extensive federal contract portfolio to supply a wide range of pharmaceutical products and medical supplies to the Defense Health Agency and other government healthcare systems. Dupixent is a specialty medication used in the treatment of various allergic and inflammatory conditions. As a critical vendor in the federal medical procurement landscape, AmerisourceBergen's competitively awarded contracts with the DLA demonstrate its capability to meet stringent federal requirements across multiple therapeutic domains, from brand-name specialty medications to generic drugs and medical devices supporting military healthcare operations domestically and internationally.
Quick answers
Who was awarded contract SPE2DR26F5F0N?
SPE2DR26F5F0N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F5F0N worth?
The government has obligated $15,873 on SPE2DR26F5F0N.
Is contract SPE2DR26F5F0N an order under another contract?
Yes. SPE2DR26F5F0N is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F0N competed?
The extent of competition for SPE2DR26F5F0N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award